<DOC>
	<DOCNO>NCT01211795</DOCNO>
	<brief_summary>Intra-Oral Topical Ketoprofen gel , apply branch trigeminal nerve , show prevent migraine use daily 3 month open label study . This randomized , double-blind , placebo control phase III prevention trial determine safety efficacy .</brief_summary>
	<brief_title>Topical Intra-Oral Ketoprofen Migraine Prevention</brief_title>
	<detailed_description>This 4 month trial . During first month , prospective headache diary maintain . Migraine frequency , severity ( 1-10 ) , duration , headache medication record . Patients randomize receive active gel placebo gel double blind fashion . Gel apply posterior maxilla daily 3 month . A daily headache diary , outline , maintain throughout trial . Patients may continue take migraine medication , need . No new migraine therapy may start trial .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>IHS Migraine without aura 18 y.o . old least 4 migraine per month pregnancy headache condition chronic daily headache allergy sensitivity NSAIDs severe illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Prevention</keyword>
	<keyword>Treatment</keyword>
	<keyword>Ketoprofen</keyword>
	<keyword>Trigeminal nerve</keyword>
</DOC>